Immunologic effects of yogurt

American Journal of Clinical Nutrition

Volumn 71, Issue 4, 2000, Pages 861-872

  Meydani, Simin Nikbin ^a   Ha, Woel Kyu ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

Asthma; Bifidobacterium; Cancer; Enterococcus; Gastrointestinal disorders; Immune system; Immunostimulatory effects; Infection; Lactic acid bacteria; Lactobacillus; Review; Salmonella; Streptococcus; Yogurt

Indexed keywords

CYTOKINE; YOGHURT;

AGED; ANTIBODY PRODUCTION; ASTHMA; CANCER; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DELAYED HYPERSENSITIVITY; DISEASE CONTROL; ENTEROCOCCUS; FLOW CYTOMETRY; GASTROINTESTINAL DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFECTION; LACTIC ACID BACTERIUM; LACTOBACILLUS BIFIDUS; LYMPHOCYTE; NONHUMAN; PHAGOCYTOSIS; REVIEW; SALMONELLA; STREPTOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; ENTEROCOCCUS; LACTOBACILLUS; SALMONELLA; STREPTOCOCCUS;

EID: 0034069779     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.4.861     Document Type: Review

References (162)

1. Bourlioux P, Pochart P. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988;56:217-58.
2. Rasic JL, Kurmann JA. Fermented fresh milk products and their cultures. Copenhagen: Technical Dairy Publishing House, 1978.
3. Shahani KM, Chandan RC. Nutritional and healthful aspects of cultured and culture-containing dairy foods. J Dairy Sci 1979; 62:1685-94.
4. Metchnikoff E. The prolongation of life. 1st ed. New York: GP Putman's Sons, 1908.
5. Fernandes CF, Shahani KM. Anticarcinogenic and immunological properties of dietary lactobacilli. J Food Prot 1990;53:704-10.
6. Solis-Pereyra B, Lemonnier D. Induction of human cytokines by bacteria used in dairy foods. Nutr Res 1993;13:1127-40.
7. Gerritse K, Posno M, Schellekens MM, Boersma WJA, Claassen E. Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res Microbiol 1990;141:955-62.
8. Elson CO, Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984;132:2736-41.
9. Ayebo AD, Angelo IA, Shahani KM. Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in humans. Milchwissenschaft 1980;25:730-3.
10. Gilliland SE, Speck ML. Antagonistic action of Lactobacillus acidophilus toward intestinal and foodborne pathogens in associative cultures. J Food Prot 1977;40:820-3.
11. Gilliland SE, Speck ML, Nauyok GF. Influence of consuming nonfermented milk containing Lactobacillus acidophilus on fecal flora of healthy males. J Dairy Sci 1978;61:1-5.
12. Prajapati J, Shah K, Dave JM. Nutritional and therapeutic benefits of a blended-spray dried acidophilus preparation. J Cult Dairy Prod 1986;21:16-7.
13. Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol Rev 1987;46:343-56.
14. Fernandes CF, Shahani KM, Amer MA. Control of diarrhea by lactobacilli. J Appl Nutr 1988;40:32-43.
15. Friend BA, Shahani KM. Antitumor properties of lactobacilli and dairy products fermented by lactobacilli. J Food Prot 1984;47:717-23.
16. Gilliland SE. Acidophilus milk products: a review of potential benefits to consumers. J Dairy Sci 1989;72:2483-94.
17. Hohmann A, Schmidt G, Rowley D. Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia and Salmonella-Escherichia coli hybrid strains. Infect Immun 1979;25:27-33.
18. Pierce NF, Cray JWC, Kaper JB, Mekalanos JJ. Determination of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae 01 in rabbits. Infect Immun 1988;56:142-8.
19. Alm L, Pettersson L. Survival rate of lactobacilli during digestion. An in vitro study. Am J Clin Nutr 1980;33(suppl):S2543 (abstr).
20. Robins-Browne RM, Path FF, Levine MM. The fate of ingested lactobacilli in the proximal small intestine. Am J Clin Nutr 1981; 34:514-9.
21. Kolar JC, Levitt MD, Aouji M, Savaiano DA. Yogurt - an autodigesting source of lactose. N Engl J Med 1984;310:1-3.
22. Pochart P, Dewit O, Desjeux JF, Bourlioux P. Viable starter culture, beta-galactosidase activity, and lactose in duodenum after yogurt ingestion in lactase-deficient humans. Am J Clin Nutr 1989; 49:828-31.
23. Martini MC, Bollweg GL, Levitt MD, Savaiano DA. Lactose digestion by yogurt beta-galactosidase: influence of pH and microbial cell integrity. Am J Clin Nutr 1987;45:432-6.
24. Marteau P, Flourie B, Pochart P, Chastang C, Desjeux JF, Rambaud JC. Effect of the microbial lactase (EC 3.2.1.23) activity in yogurt on the intestinal absorption of lactase-deficient humans. Br J Nutr 1990;64:71-9.
25. Saxelin M. Colonization of the human gastrointestinal tract by probiotic bacteria. Nutr Today 1996;31(suppl):5S.
26. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987;70:1-12.
27. Clark PA, Martin JH. Selection of bifidobacteria for use as dietary adjuvants in cultured dairy foods: III. Tolerance to stimulated bile concentrations of human small intestines. Cult Dairy Prod J 1994; 29:18-21.
28. Bernet MF, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interaction. Appl Environ Microbiol 1993;59:4121-8.
29. Elo S, Salminen S. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett Appl Microbiol 1991;13:154-6.
30. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LAI binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35:483-9.
31. Muscettola M, Massai L, Tanganelli C, Grasso G. Effects of lactobacilli on interferon production in young and aged mice. Ann N Y Acad Sci 1994;717:226-32.
32. De Simone C, Bianchi Salvadori B, Negri M, Ferrazzi M, Baldinelli L, Vesely R. The adjuvant effect of yogurt on production of gamma-interferon by Con A stimulated human peripheral blood lymphocytes. Nutr Rep Int 1986;33:419-33.
33. Solis-Pereyra B, Lemonnier D. Induction of 2′-5′ A synthetase activity and interferon in humans by bacteria used in dairy products. Eur Cytokine Netw 1991;2:137-40.
34. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor-alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996;64:5403-5.
35. Halpern GM, Vruwink KG, van de Water J, Keen CL. Gershwin ME. Influence of long-term yogurt consumption in young adults. Int J Immunother 1991;7:205-10.
36. Aattouri N, Lemonnier D. Production of interferon induced by Streptococcus thermophihis: role of CD4+ and CD8+ lymphocytes. Nutr Biochem 1997;8:25-31.
37. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997; 66(suppl):515S-20S.
38. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7.
39. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intakes. FEMS Immunol Med Microbiol 1994;10:55-64.
40. Losacco T, De Leo G, Punzo C, et al. Immune evaluations in cancer patients after colorectal resection. G Chir 1994;15:429-32.
41. De Simone C, Bianchi Salvadori B, Jirillo E, Baldinelli L, Bitonti F, Vesely R. Modulation of immune activities in humans and animals by dietary lactic acid bacteria. In: Chandan RC, ed. Yogurt: nutritional and health properties. McLean, VA: Kirby Lithographics, 1989:201-14.
42. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: Greene Publishing Association. 1994.
43. Galabru J, Robert N, Buffett-Janvresse C, Riviere Y, Hovanessian AG. Continuous production of interferon in normal mice: effect of antiinterferon globulin, sex, age, strain and environment on the levels of 2′-5′ A synthetase and p67K kinase. J Gen Virol 1985;66:711-8.
44. Bocci V, Paulesu L, Pessina GP, Nicoletti C. The physiological interferon response. IX. Interferon activity in rabbit lymph after intraduodenal administration of alimentary lectins. Lymphokine Res 1988;7:49-59.
45. Bocci V. Production and role of interferon in physiological conditions. Biol Rev 1981;56:49-85.
46. Bocci V. The physiological interferon response. Immunol Today 1985;7:7-9.
47. Merlin G, Vanderhoven C, Stefanos S, et al. Evidence for interferon (IFN) induction in mice and humans by a fractions of bacterial extracts (SLO4) in vitro and oral administration in vivo. Antiviral Res 1985;1(suppl):161-6.
48. Trapp CL, Chang CC, Halpern GM, Keen CL, Gershwin ME. The influence of chronic yogurt consumption on populations of young and elderly adults. Int J Immunother 1993;9:53-64.
49. Solis-Pereyra B, Aattouri N, Lemonnier D. Role of food in the stimulation of cytokine production. Am J Clin Nutr 1997;66(suppl): 521S-25S.
50. Roberts-Thomson IC, Whittingham S, Youngchaiyud U, Mackay IR. Ageing, immune response and mortality. Lancet 1974;2:368-70.
51. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in the aged. J Gerontol Med Sci 1990;45:M45-8.
52. Cohn JR, Hohl CA, Buckley CE. The relationship between cutaneous cellular immune responsiveness and mortality in a nursing home population. J Am Geriatr Soc 1983;31:808-9.
53. Christou NV, Tellado-Rodriguez J, Chartrand L, et al. Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response. Ann Surg 1989;210:69-77.
54. Kniker WK, Anderson CT, Roumiantzeff M. The multi-test system: a standardized approach to evaluation of delayed hypersensitivity and cell mediated immunity. Ann Allergy 1979;43:73-9.
55. Beharka AA, Redican S, Leka L, Meydani SN. Vitamin E status and immune function. In: McCormick DB, Suttie JW, Wagner C. eds. Methods in enzymology: vitamins and coenzymes. Orlando, FL: Academic Press, Inc. 1997:247-63.
56. Sunday ME, Weinberger JZ, Benacerraf B, Dorf ME. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. IV. Specificity of cutaneous sensitivity responses. J Immunol 1980;125:1601-5.
57. De Simone C, Vesely R, Bianchi Salvadori B, Jirillo E. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993;9:23-8.
58. Puri P, Rattan A, Bijlani RL, Mahapatra SC, Nath I. Splenic and intestinal lymphocyte proliferation response in mice fed milk or yogurt and challenged with Salmonella tythimurium. Int J Food Sci Nutr 1996;47:391-8.
59. Puri P, Mahapatra SC, Bijlani RL, Prasad HK, Nath I. Feed efficiency and splenic lymphocyte proliferation response in yogurt-and milk-fed mice. Int J Food Sci Nutr 1994;45:231-5.
60. Pierce NF, Kaper JB, Mekalanos JJ, Cray WC Jr, Richardson K. Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae 01 in rabbit intestine. Infect Immun 1987;55: 477-81.
61. Hatcher GE, Lambrecht RS. Augmentation of macrophage phagocyte activity by cell free extracts of selected lactic acid-producting bacteria. J Dairy Sci 1993;76:2485-92.
62. Takahashi T, Oka T, Iwana H, Kuwata T, Yamamoto Y. Immune response of mice to orally administered lactic acid bacteria. Biosci Biotechnol Biochem 1993;57:1557-60.
63. Rook G. Immunity to bacteria. In: Roitt I, Brostoff J, Male D, eds. Immunology. St. Louis: Mosby, 1989.
64. Peeters T, Vantrappen G. The paneth cell: a source of intestinal lysozyme. Gut 1975;16:553-8.
65. Ellouz F, Adam A, Ciorbaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res 1974;59:1317-25.
66. Adams A, Petit JF, Lefrancier P, Lederer E. Muramyl peptides. Mol Cell Biochem 1981;41:27-47.
67. Stewart-Tull DES. The immunological activities of bacterial peptidoglycans. Annu Rev Microbiol 1980;34:311-40.
68. Dziarski R. Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J Biol Chem 1991;266:4713-8.
69. Bogdanov IG, Dalev PG, Gurevich LA, et al. Antitumor glycopeptides from Lactobacillus bulgaricus cell wall. FEBS Lett 1975;57: 259-61.
70. Iribe H, Koga T, Onoue K, Kotani S, Kusumoto S, Shiba T. Macrophage-stimulating effect of synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T cell activating monokines. Cell Immunol 1981;64:73-83.
71. Iribe H, Koga T, Onoue K. Production of T cell-activating monokine of guinea pig macrophages induced by MDP and partial characterization of the monokine. J Immunol 1982;129:1029-1.
72. Oppenheim JJ, Togawa A, Chedid L, Mizel S. Components of microbacteria and muramyl dipeptide with adjuvant activity induced lymphocyte activating factor. Cell Immunol 1980;50:71-81.
73. Tufano MA, Cipollaro de l'Ero G, Ianniello R, Galdiero M, Galdiero F. Protein A and other surface components of Staphylococcus aureus stimulate production of IL-1 alpha, IL-4, 1L-6, TNF and IFN-gamma. Eur Cytokine Net 1991;2:361-6.
74. Sato K, Saito H, Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol Immunol 1988;32:689-98.
75. Parant M, Parant F, Chedid L. Enhancement of the neonate's non-specific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant. Proc Natl Acad Sci U S A 1978;75: 3395-9.
76. Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972;36:407-77.
77. Popova P, Guencheva G, Davidkova G, et al. Stimulating effect of DEODAN (an oral preparation from Lactobacillus bulgaricus "LB51") on monocytes/-macrophages and host resistance to experimental infections. Int J Immunopharmcol 1993;15:25-37.
78. Namba Y, Hidaka Y, Taki K, Morimoto T. Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs. Infect Immun 1981;31:580-3.
79. Sato K, Saito H, Tomioka H, Yokokura T. Enhancement of host resistance against Listeria infection by Lactobacillus casei: efficacy of cell wall preparation of Lactobacillus casei. Microbiol Immunol 1988;32:1189-200.
80. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Grampositive cell walls stimulate synthesis of tumor necrosis factor-alpha and interleukin-6 by human monocytes. Infect Immun 1994;62: 2715-21.
81. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991;59:4614-20.
82. Riesenfeld-Orn I, Wolpe S, Garcia-Bustos JF, Hoffman MK, Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun 1989;57:1890-3.
83. Yamamoto A, Usami H, Nagamuta M, et al. The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis. Br J Cancer 1985;53:739-42.
84. Rangavajhyala N, Shahani M, Sridevi G, Srikumaran S. Non-lipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutr Cancer 1997;28:130-4.
85. Kado-Oka Y, Fujiwara S, Hirota T. Effect of bifidobacteria cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenschaft 1991;46:626-30.
86. Moineau S, Goulet J. Effect of feeding fermented milks on the pulmonary macrophage activity in mice. Milchwissenschaft 1991; 46:551-4.
87. Parker F, Migliore-Samour D, Floch F, et al. Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. Eur J Biochem 1984;145:677-82.
88. Meisel H, Schlimme F. Milk proteins: precursors of bioactive peptides. Trends Food Sci Tech 1990;1:41-5.
89. Tateishi N, Higashi T, Shinya S, Naruse A, Sakamoto Y. Studies on the regulation of glutathione level in rat liver. J Biochem 1974; 75:93-103.
90. Fidelus RK, Tsan MF. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell Immunol 1986; 97:155-63.
91. Fidelus RK, Ginouves P, Lawrence D, Tsan MF. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp Cell Res 1987;170:269-75.
92. Smyth MJ. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol 1991;146:1921-7.
93. Wu D, Meydani SN, Sastre J, Hayek M, Meydani M. In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J Nutr 1994;124:655-63.
94. Messina JP, Lawrence DA. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol 1989;143:1974-81.
95. MacDermott RP, Bertovich MJ, Bragdon MJ, Nash GS, Leusch MS, Wedner HJ. Inhibition of cell-mediated cytotoxicity by 2-cyclohexene-1-one: evidence for a role for glutathione and/or glutathione-protein interactions in cytolysis. Immunology 1986;57:521-6.
96. Younes M, Craig G, Stacey NH. Cell-mediated cytotoxicity by natural killer cells, lipid peroxidation and glutathione. Experientia 1986;42:1257-9.
97. Yamauchi A, Bloom ET. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J Immunol 1993;151:5535-44.
98. McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers GW. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 1995;125:809-16.
99. Bounous G, Baruchel S, Falutz J, Gold P. Whey protein as a food supplement in HIV-seropositive individuals. Clin Invest Med 1993;16:204-9.
100. Wong CW, Watson DL. Immunomodulatory effects of dietary whey protein in mice. J Dairy Res 1995;62:359-68.
101. Bounous G, Kongshavn PAL. Influence of dietary proteins on the immune system of mice. J Nutr 1982;112:1747-55.
102. Bounous G, Papenburg R, Kongshavn P, Gold P, Fleizer D. Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin Invest Med 1988;11:213-7.
103. Birt DF, Baker PY, Hruza DS. Nutritional evaluations of three dietary levels of lactalbumin throughout the lifespan of two generations of Syrian hamsters. J Nutr 1982;112:2151-60.
104. Boccignone M, Brigidi R, Sarra C. Studi effettuati sulla composizione in trigliceridi ed acidi grassi liberi nello yogurt preparato dalatte vaccino, pecorinoe caprino. (Studies on triglyceride and free fatty acid composition of yogurt prepared from cow, goat, and sheep milk.) Ann Fac Med Vet (Torino) 1984;28:223-33 (in Italian).
105. Rao R, Reddy JC. Effects of lactic acid fermentation of milk on milk lipids. J Food Sci 1984;49:748-50.
106. Shantha NC, Ram LN, O'Leary J, Hicks CL, Decker EA. Conjugated linoleic acid concentrations in dairy products as affected by processing and storage. J Food Sci 1995;60:695-8.
107. Aneja RP, Murthi TN. Conjugated linoleic acid contents of Indian curd and ghee. Indian J Dairy Sci 1990;43:231-8.
108. Terre S. Characterisation et production en continu de biometabolite du yogurt. (Characterization and continuous production of certain biometabolites of yogurt.) Mem INRA Rennes 1985;1-24 (in French).
109. Balasubramanya NN, Natarajan AM, Rao RV. Availability of calcium and phosphorus for albino rats from yogurt. Asian J Dairy Sci 1984;3:131-4.
110. Lindahl-Kiessling KM. Calcium dependency of the binding and mitogenicity of phytohemagglutinin. Differentiation between calcium-dependent and independent binding events. Exp Cell Res 1976;103:151-7.
111. Gearing AJH, Wadhwa M, Perris AD. Interleukin 2 stimulates T cell proliferation using a calcium flux. Immunol Lett 1985;10:297-302.
112. Gately MK, Martz E. Early steps in specific tumor lysis by sensitized mouse T lymphocytes. J Immunol 1979;122:482-9.
113. Ayebo AD, Shahani KM, Dam R, Friend BA. Ion exchange separation of the antitumor component(s) of yogurt dialysate. J Dairy Sci 1982;65:2388-90.
114. Biffi A, Coradini D, Larsen R, Riva L, Fronzo GD. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 1997;28:93-9.
115. Perdigon G, Nader de Ruiz Holgado ME, Alvareez S, Oliver G, Media M, Pesce de Ruiz Holgado AA. Effect of mixture of Lactobacillus casei and Lactobacillus acidophilus administered orally on the immune system in mice. J Food Prot 1986;49:986-98.
116. Farmer RE, Shahani KE, Reddy GV. Inhibitory effect of yogurt components upon the proliferation of ascites tumor cells. J Dairy Sci 1975;58:787-8.
117. Friend BA, Farmer RE, Shahani KM. Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor cells. Milchwissenschaft 1982;37:708-10.
118. Goldin BR, Gorbach SL. The effect of oral administration of lactobacillus and antibiotics on intestinal bacterial activity and chemical induction of large bowel tumors. Dev Ind Microbiol 1983;25:139-50.
119. Goldin BR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 1984;39:756-61.
120. Kato I, Yokokura T, Mutai M. Macrophage activation by Lactobacillus casei in mice. Microbiol Immunol 1983;27:611-8.
121. Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and immunonitrogen oxidation to nitrite. Science 1987;253:473-6.
122. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
123. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991;49:380-7.
124. Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell. N Engl J Med 1980;303:622-6.
125. Somers SD, Whisnant CC, Adams DQ. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages. J Immunol 1986;136:1490-6.
126. Keller R, Keist R, Joller PW. Macrophage response to bacteria and bacterial products: modulation of Fc-gamma receptors and secretory and cellular activities. Immunology 1994;81:161-6.
127. Hashimoto S, Nomoto K, Matsuzaki T, Yokokura T, Mutai M. Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei. Infect Immun 1984;44:61-7.
128. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado AA. Effect of perorally administered Lactobacilli on macrophage activation in mice. Infect Immun 1986;53:404-10.
129. Goulet J, Saucier L, Moineau S. Stimulation of the non-specific immune response of mice by fermented milks. In: National Yogurt Association, ed. Yogurt: nutritional and health properties. McLean, VA: Kirby Lithographics, 1989:187-200.
130. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado AA. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988;63:17-23.
131. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado AA. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J Dairy Sci 1987;70:919-26.
132. Kitazawa H, Mataumura K, Itoh T, Yamauchi T. Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. Microbiol Immunol 1992;36:311-5.
133. Perdigon G, Alvarez S, Pesce de Ruiz Holgado AA. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 1991;58:485-96.
134. Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. Immune system stimulation by probiotics. J Dairy Sci 1995;78:1597-606.
135. Claassen I, Osterhaus A, Boersma W, Schellekens M, Claasen E. Fluorescent labeling of virus, bacteria, and iscoms: in vivo systemic and mucosal localization patterns. Adv Exp Med Biol 1995;371B: 1485-9.
136. De Simone C, Vesely R, Negri R, et al. Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt. Immunopharmacol Immunotoxicol 1987;9:87-100.
137. De Simone C, Jirillo E, Bianchi Salvadori B. Stimulation of host resistance by a diet supplemented with yogurt. Adv Biosci 1988; 68:229-33.
138. Wheeler JG, Bogle ML, Shema SJ, et al. Impact of dietary yogurt on immune function. Am J Med Sci 1997;313:120-3.
139. Wheeler JG, Shema SI, Bogle ML, et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann Allergy Asthma Immunol 1997;79:229-33.
140. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32:141-4.
141. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhea. Arch Dis Child 1995;72:51-3.
142. Kawai Y, Watanabe T, Suegara N, Mutai M. Distribution and colonization of human fecal streptococci. Am J Clin Nutr 1980; 33:2458-61.
143. Marteau P, Pochart P, Bouhnik Y, Rambaud JC. The fate and effects of transiting, nonpathogenic microorganisms in the human intestine. In: Simopoulos AP, Corring T, Rerat A, eds. Intestinal flora, immunity, nutrition and health. Basel, Switzerland: Karger, 1993:1-17.
144. Le MG, Moulton LH, Hill C, Kramer A. Consumption of dairy products and alcohol in a case-control study of breast cancer. J Natl Cancer Inst 1986;77:633-6.
145. Van't Veer P, Dekker JM, Lamers JWJ, et al. Consumption of fermented milk products and breast cancer: a case control study in the Netherlands. Cancer Res 1989;49:4020-3.
146. Van't Veer P, van Leer EM, Rietdijk A, et al. Combination of dietary factors in relation to breast-cancer occurrence. Int J Cancer 1991; 47:649-53.
147. Cramer DW, Harlow BL, Willett W, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989;2:66-71.
148. Hitchins AD, McDonough FE. Prophylactic and therapeutic aspects of fermented milk. Am J Clin Nutr 1989;46:675-84.
149. Reddy GV, Friend BA, Shahani KM, Farmer RE. Antitumor activity of yogurt components. J Food Prod 1983;46:159-64.
150. Goldin BR, Gorbach SL. Effect of Latobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst 1980;64:263-5.
151. Shackelford LA, Ramkishan Rao D, Chawan CB, Pulusani SR. Effect of feeding fermented milk on the incidence of chemically induced colon tumors in rats. Nutr Cancer 1983;5:159-64.
152. Tsuru S, Shinomiya N, Taniguchi M, Shimazaki H, Tanigawa K, Nomoto K. Inhibition of tumor growth by dairy products. J Clin Lab Immunol 1988;25:177-83.
153. Goldin BR, Gorbach SL. Alternations in fecal microflora enzymes related to diet, age, Lactobacillus supplements and dimethylhydrazine. Cancer 1977;40:2421-6.
154. Lidbeck A, Nord C, Gustafsson JA, Rafter J. Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur J Cancer Prev 1992;5:341-53.
155. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium logum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4.5-f] quinoline, a food mutagen. Cancer Res 1993;53:3914-8.
156. Goldin BR, Gualtieri LJ, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer 1996;25:197-204.
157. Dodds KL, Collins-Thompson DL. Nitrite tolerance and nitrite reduction in lactic acid bacteria associated with cured meat products. Int J Food Microbiol 1984;1:197-204.
158. Kim HS. Characterization of lactobacilli and bifidobacteria as applied to dietary adjuvants. J Cult Dairy Prod 1988;23:6-9.
159. Fernandes CF, Shahani KM. Modulation of antibiosis by lactobacilli and yogurt and its helpful and beneficial significance. In: Chandan RC, ed. Yogurt: nutritional and health properties; 1989: 145-60.
160. Gorbach SL, Chang TW, Goldin BR. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;2:1519 (letter).
161. Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987;2:43 (letter).
162. Shida K, Makino K, Morishita A, et al. Lactobacillus casei inhibit antigen induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998;115:278-87.